Medtronic plc

Last price update: 02 Oct 24 23:00 GMT

Price:
$89.12
Open:
$89.54
Previous close:
$90.00
Day's range:
$88.98 - $89.69
Year's range:
$68.84 - $91.49
Net Income per Share:
2.97
Price-to-Earnings ratio:
30.01
52-week Price Range:
$86.03
Volume:
$3,193,241.00
Average volume:
$6,494,538.00

Company profile for Medtronic plc

Medtronic plc logo

Medtronic plc is a leading medical technology company. Headquartered in Dublin, Ireland, it was founded in 1949 by Earl E. Bakken and is the world’s largest medical technology company and the largest medical device manufacturer. Medtronic designs, manufactures and markets medical devices, therapies and services to treat diseases and medical conditions, restore health, and improve quality and longevity of life for people with chronic diseases.

Medtronic’s device-based medical therapies are sold to healthcare systems, physicians, clinicians, and patients worldwide. It operates through four global business units: Cardiovascular, Medical Surgical, Neuroscience, and Diabetes Operating Unit. Its Cardiovascular Portfolio offers implants and therapies that treat various heart conditions, such as implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; aortic valves; surgical valve replacement and repair products; endovascular stent grafts and accessories; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products, among others. The company’s Medical Surgical Portfolio offers therapies to treat diseases and medical conditions such as hernia, chronic lung disease, and gastrointestinal diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Similarly, the Neuroscience Portfolio segment offers products to treat diseases and medical conditions such as spinal and neurosurgery, pain management, anesthesiology, orthopedic surgery, urology, and interventional radiology, among others. The Diabetes Operating Unit segment offers products to help people with diabetes manage their healthcare, including insulin pumps and consumables, continuous glucose monitoring systems, and smart insulin pen systems.

Today, Medtronic has more than 87,000 employees and a presence in more than 160 countries, and is listed on the New York Stock Exchange (NYSE). The company reported sales of over 30 billion dollars in 2019 and has a market capitalization of approximately $125 billion and is a member of the S&P 500 index. It has consistently been one of the most highly-valued companies in the world, being named one of the World’s Most Respected Companies for six consecutives years (2014-2020).

Stock exchanges:
NYSE
Sector:
Healthcare
Industries:
Medical Devices
Ticker:
MDT
CIK:
0001613103
ISIN:
IE00BTN1Y115
Website:
https://www.medtronic.com
Phone:
353 1 438 1700
Origin:
Ireland
Employees:
95,000